Human medicines European public assessment report (EPAR): Theralugand, lutetium (177Lu) chloride, Date of authorisation: 22/11/2024, Status: Authorised
Human medicines European public assessment report (EPAR): Fosavance, alendronic acid,colecalciferol, Date of authorisation: 24/08/2005, Revision: 30, Status: Authorised
Submission of Manufacturers, Manufacturing Business Operations (MBOs) and structured pack size data to Product Management Service (PMS), Online, European Medicines Agency, Amsterdam, the Netherlands, from 25 November 2024, 10:00 (CET) to 25 November 2024, 11:30 (CET)
Three-year work plan for the Quality Drafting Group (QDG) of the Committee on Herbal Medicinal Products (HMPC)
Data protection notice for the Experts Management Tool and the handling of competing interests
Jcovden : Periodic safety update report assessment 25 February 2023 to 24 February 2024
Guidance on the electronic submission of information on investigational medicinal products for human use in the Extended EudraVigilance medicinal product dictionary (XEVMPD)
How to pay
How to pay fees and charges levied by EMA: Guidance to marketing authorisation holders and applicants
How to pay fees and charges levied by EMA: Guidance to marketing authorisation holders and applicants